"An essential caretaker of the San Fernando, Santa Clarita and Simi Valley Communities, Providence Holy Cross Medical Center offers both inpatient and outpatient health services - all of which embrace a holistic and family-centered approach to care. From a state-of-the-art cancer center to emergency and trauma services, we work tirelessly to provide for your every physical, emotional, social and spiritual need."

During the past decade, Providence Holy Cross Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Holy Cross Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 8 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Axio Research. LLC" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Holy Cross Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Providence Holy Cross Medical Center" are "Breast Cancer" (3 trials), "Head and Neck Cancer" (2 trials), "Anal Cancer" (1 trials), "Atherosclerosis" (1 trials) and "BCLC Stage A Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Providence Holy Cross Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Holy Cross Medical Center" are "Drug" (17 trials), "Radiation" (11 trials), "Biological" (6 trials), "Other" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (5 trials), "Laboratory Biomarker Analysis" (4 trials), "cisplatin" (4 trials), "Radiation Therapy" (2 trials) and "adjuvant therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Holy Cross Medical Center" are 17 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Holy Cross Medical Center". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Providence Holy Cross Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Holy Cross Medical Center, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".